Galectin-3 also independently predicted the 1-year combined endpoint of cardiac death, heart transplantation and/or HF hospitalization (unadjusted HR 1.04 [1.02–1.06] per unit increase, p = 0.003). This evidence concerns the gene LGALS3 and hydrops fetalis.